250 related articles for article (PubMed ID: 11579092)
1. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux.
Leventhal AR; Chen W; Tall AR; Tabas I
J Biol Chem; 2001 Nov; 276(48):44976-83. PubMed ID: 11579092
[TBL] [Abstract][Full Text] [Related]
2. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
Maor I; Mandel H; Aviram M
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
[TBL] [Abstract][Full Text] [Related]
3. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent.
Skiba PJ; Zha X; Maxfield FR; Schissel SL; Tabas I
J Biol Chem; 1996 Jun; 271(23):13392-400. PubMed ID: 8662777
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content.
Okwu AK; Xu XX; Shiratori Y; Tabas I
J Lipid Res; 1994 Apr; 35(4):644-55. PubMed ID: 8006519
[TBL] [Abstract][Full Text] [Related]
5. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
6. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
Breiden B; Sandhoff K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux.
Yancey PG; Jerome WG
J Lipid Res; 2001 Mar; 42(3):317-27. PubMed ID: 11254742
[TBL] [Abstract][Full Text] [Related]
8. Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism.
Schmitz G; Robenek H; Beuck M; Krause R; Schurek A; Niemann R
Arteriosclerosis; 1988; 8(1):46-56. PubMed ID: 2829803
[TBL] [Abstract][Full Text] [Related]
9. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL.
Wang N; Ranalletta M; Matsuura F; Peng F; Tall AR
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1310-6. PubMed ID: 16556852
[TBL] [Abstract][Full Text] [Related]
10. Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages.
Schmitz G; Beuck M; Fischer H; Nowicka G; Robenek H
J Lipid Res; 1990 Oct; 31(10):1741-52. PubMed ID: 2079600
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
Marathe S; Choi Y; Leventhal AR; Tabas I
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally.
Dhaliwal BS; Steinbrecher UP
J Lipid Res; 2000 Oct; 41(10):1658-65. PubMed ID: 11013308
[TBL] [Abstract][Full Text] [Related]
13. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages.
Langer C; Huang Y; Cullen P; Wiesenhütter B; Mahley RW; Assmann G; von Eckardstein A
J Mol Med (Berl); 2000; 78(4):217-27. PubMed ID: 10933584
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelinase treatment of low density lipoprotein and cultured cells results in enhanced processing of LDL which can be modulated by sphingomyelin.
Gupta AK; Rudney H
J Lipid Res; 1992 Dec; 33(12):1741-52. PubMed ID: 1479284
[TBL] [Abstract][Full Text] [Related]
15. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
[TBL] [Abstract][Full Text] [Related]
16. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.
Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1723-30. PubMed ID: 18669882
[TBL] [Abstract][Full Text] [Related]
17. The efflux of lysosomal cholesterol from cells.
Johnson WJ; Chacko GK; Phillips MC; Rothblat GH
J Biol Chem; 1990 Apr; 265(10):5546-53. PubMed ID: 2318824
[TBL] [Abstract][Full Text] [Related]
18. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
[TBL] [Abstract][Full Text] [Related]
19. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
20. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking.
Leventhal AR; Leslie CC; Tabas I
J Biol Chem; 2004 Feb; 279(9):8084-92. PubMed ID: 14638686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
